S Partelli
Overview
Explore the profile of S Partelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
339
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mapelli P, Bezzi C, Palumbo D, Canevari C, Ghezzo S, Samanes Gajate A, et al.
Eur J Nucl Med Mol Imaging
. 2022 Feb;
49(7):2352-2363.
PMID: 35156146
Purpose: To explore the role of fully hybrid Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine tumours (PanNETs) undergoing surgery. Methods: One...
2.
Andreasi V, Partelli S, Manzoni M, Muffatti F, di Filippo L, Crippa S, et al.
J Endocrinol Invest
. 2022 Feb;
45(6):1209-1217.
PMID: 35122631
Purpose: No single reliable biomarker is available for nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs). Vasostatin-1 (VS-1), the N-terminal fragment of chromogranin A (CgA), seems to be a more accurate biomarker compared...
3.
Andreasi V, Ricci C, Partelli S, Guarneri G, Ingaldi C, Muffatti F, et al.
J Endocrinol Invest
. 2021 Nov;
45(4):705-718.
PMID: 34773595
Purpose: Patients submitted to curative surgery for non-functioning pancreatic neuroendocrine neoplasms (NF-PanNENs) exhibit a variable risk of disease relapse. Aims of this meta-analysis were to estimate the rate of disease...
4.
Bezzi C, Mapelli P, Presotto L, Neri I, Scifo P, Savi A, et al.
Eur J Nucl Med Mol Imaging
. 2021 Apr;
48(12):4002-4015.
PMID: 33835220
Purpose: To present the state-of-art of radiomics in the context of pancreatic neuroendocrine tumors (PanNETs), with a focus on the methodological and technical approaches used, to support the search of...
5.
Ricci C, Partelli S, Landoni L, Rinzivillo M, Ingaldi C, Andreasi V, et al.
Br J Surg
. 2021 Mar;
108(7):811-816.
PMID: 33724300
Background: Outcomes after surgery for sporadic pancreatic neuroendocrine neoplasms (Pan-NENs) were evaluated. Methods: This multicentre study included patients who underwent radical pancreatic resection for sporadic non-functioning Pan-NENs. In survival analysis,...
6.
Rossi R, Milanetto A, Andreasi V, Campana D, Coppa J, Nappo G, et al.
J Endocrinol Invest
. 2021 Mar;
44(10):2227-2234.
PMID: 33651317
Purpose: Pretreatment staging is the milestone for planning either surgical or endoscopic treatment in duodenal neuroendocrine neoplasms (dNENs). Herein, a series of surgically treated dNEN patients was evaluated to assess...
7.
Massironi S, Campana D, Pusceddu S, Albertelli M, Faggiano A, Panzuto F, et al.
Dig Liver Dis
. 2021 Mar;
53(3):367-374.
PMID: 33645508
Background: Patients with sporadic neuroendocrine neoplasms may exhibit a higher risk of a second primary tumor than the general population. Aim: This study aimed to analyze the occurrence of second...
8.
Mapelli P, Fallanca F, Franchini A, Albarello L, Vanoli E, Partelli S, et al.
Eur J Nucl Med Mol Imaging
. 2020 Mar;
47(11):2713-2714.
PMID: 32170346
No abstract available.
9.
Pergolini I, Crippa S, Pagnanelli M, Belfiori G, Pucci A, Partelli S, et al.
BJS Open
. 2019 Oct;
3(5):646-655.
PMID: 31592095
Background: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease characterized by complex biological features and poor prognosis. A prognostic stratification of PDAC would help to improve patient management. The aim...
10.
Genc C, Falconi M, Partelli S, Muffatti F, van Eeden S, Doglioni C, et al.
Ann Surg Oncol
. 2018 May;
25(8):2467-2474.
PMID: 29789972
Background: Despite evidence of different malignant potentials, postoperative follow-up assessment is similar for G1 and G2 pancreatic neuroendocrine tumors (panNETs) and adjuvant treatment currently is not indicated. This study investigated...